Why is Pfizer sharing its COVID-19 pill but not its vaccine?

As big pharma refuses to share its COVID vaccine secrets, the WHO hires a South African lab to crack the mRNA code.

Pfizer’s chief executive Albert Bourla says his COVID-19 oral antiviral drug is “a real game changer”. He claims the pill cuts the risk of hospitalisation and death by 89 percent.

But unsurprisingly campaigners are already raising concerns that the rich world will once again corner the anti-viral market. Dr Githinji Gitahi, the chief executive of Amref Health Africa, explains what needs to be done for the equitable distribution of vaccines.

German company BioNTech and Pfizer announce 90% effictive coronavirus vaccine

 German company BioNTech and its US partner Pfizer announced on Monday that early results from ongoing Phase III trials showed that their vaccine was 90% effective in preventing COVID-19 infections. The statement from the two companies is the first release of successful data from a large-scale trial of coronavirus vaccines

Coronavirus vaccine update: How close are we?

As Covid-19 cases spike in some countries, it’s clear that the pandemic isn’t slowing down. That’s why many are pinning their hopes on a vaccine. Thousands of scientists are now working on more than 150 vaccines, but none have been approved for use.